| GM food and crop developments in India (27/6/2006) | |
|
1.Govt yet to finalise GM labelling norms Item 4 relates to a the meeting a few days ago between representatives of the Coalition for GM-Free India and the governor of Madhya Pradesh. EXCERPTS: "Studies have revealed that the toxin form of Cry1Ac [as found in many Bt crops] is potent antigen in mice, following gastric administration. Specific IgG and IgM antibodies and locally produced IgA and IgG antibodies to the toxin were detected. Several human cell cultures, including colonic epithelial and liver cells, demonstrated a number of cytotoxic reactions when exposed to Bt toxins and immunologic sensitisation of farm workers has been well documented. Accordingly, it would be unwise to use Bt toxin-containing foodstuffs for human or animal diet." - Dr Arpad Pusztai (quoted in item 3) "The health ministry has washed its hands of testing food for safety. Instead, it would just rely on information provided by manufacturers and pass it on to the consumers. We want the Indian Council of Medical Research or the Indian Council of Agricultural Research to be consulted before any GM product is allowed." - Devinder Sharma (quoted in item 1) 1.Govt yet to finalise GM labelling norms The sweet and spicy corn cups that children relish at the malls could be GM corn if anti-GM groups are to be believed. But, whether they are GM or not, the common man has no way to know. The reason is that the health ministry has not finalised labelling norms for spelling out what is GM and what is not. The draft notification has been in the public domain inviting objections since March. The two-month period for public comment lapsed on May 20, while the foreign trade policy regarding GM food becomes operative from July 7. However, the ministry officials say the norms may take another six months. They are not aware of the July 7 deadline. The foreign trade policy announced in April has a clause on GM articles and provides for penal provisions for non-declaration of GM content. But this clause has been kept in abeyance pending finalisation of the labelling norms by the health ministry. "We have received a lot of objections and are in the process of examining them before finalising the norms," a top official said. The norms in any case would not be judgmental but merely providing an informed choice to consumers so that they could know what is GM and what is not, the official added. But in the interim period, there is no bio-safety mechanism at entry points to check for GM content in food articles as they exist for exotic weeds and for testing food for pesticide residue. The Department of Biotechnology is yet to take GM testing of food items into account, says Devinder Sharma of Forum for Biotechnology and Food Security, Delhi. Sweet corn imported from US is GM and so is a lot of soya oil, he says. Sharma, whose organisation is part of the larger multi-state body called Coalition Against GM, is critical of the labelling norms that have been drafted. "The health ministry has washed its hands of testing food for safety. Instead, it would just rely on information provided by manufacturers and pass it on to the consumers. We want the Indian Council of Medical Research or the Indian Council of Agricultural Research to be consulted before any GM product is allowed." 2.Mahyco files for brinjal patents NEW DELHI, JUNE 25: Farmers may have to pay a heavy price for Bt brinjal seeds when they are approved for commercial cultivation. The seed company, Mahyco has filed for patents rights over its event specific polymerase chain reaction (PCR) involved in the process of developing Bt brinjal. Bt gene has been isolated and developed by the US seed multinational, Monsanto. The same gene has been employed by its Indian partner, Mahyco in developing Bt cotton and other transgenic crops like Bt brinjal in India. Mahyco has also transferred this technology to other Indian seed company, which are its sub-licencees. The marketing joint venture, Mahyco-Monsanto Biotech (MMB) has already come under fire for charging high technology fee on Bt cotton seeds sold to farmers. The matter is subjudiced both in the Supreme Court and in the Monopolies and Restrictive Trade Practices Commission (MRTPC). MMB, at present, collects "technology fee" of Rs 900 per 450 gm pack of Bt cotton seeds. The MRTPC, in its recent interim verdict, has observed that this "technology fee" is higher than what the parent company, Monsanto charges as royalty in China. Mahyco has developed four Bt brinjal hybrids namely, MHB-4 Bt, MHB-9 Bt, MHB-80 Bt and MHBJ-99 Bt, by inserting 3 genes - cry 1 Ac (Bt gene), nptll and the plant virus promoter gene, CaMV 35S. The four Bt brinjal hybrids are awaiting nod from the Genetic Engineering Approval Committee (GEAC) for multi-locational largescale field trials. 3.In search of the right recipe Bt brinjal remains in the midst of controversy with Mahyco vouching for its health and environment safety and NGOs disputing the claims. The onus lies on GEAC to resolve the issue, says Ashok B Sharma Is Green Revolution giving way to the Gene Revolution? Notwithstanding continuing protests from NGOs, farmers' organisations and a group of scientists, the Genetic Engineering Approval Committee (GEAC) is slated to take a call, next month, on the proposal for large-scale field trials of four transgenic brinjal hybrids developed by Mahyco. The transgenic brinjals are designed to protect the crop from fruit and stem borer. That's not all on the genetically modified (GM) food crops front. Transgenic mustard and potato have completed their requisite rounds of contained field trial and are awaiting the nod for large-scale field trials. GM mustard - developed by Deepak Pental of Delhi University - has barnase-barstar genes incorporated in its genome, with claims for increasing oil content. And GM potato, developed by Asish Dutta of National Centre for Plant Genome Research by inserting genes from the amaranthus plant, is claimed to have improved protein content. Mustard and potatoes are winter crops and can wait for further trials in the next season. The case is different for brinjal that can be grown in both the seasons. GM mustard was earlier developed by ProAgro in collaboration with Aventis and PGS. After large-scale field trials when it came up for approval for commercialisation, the GEAC turned down the proposals in April 2003 saying data presented on health safety was enough convincing. If GM brinjal qualifies the rounds of large-scale field trials and is subsequently approved for commercialisation, it would be the country's first transgenic food crop. At this juncture both the advocates and opponents of Bt brinjal are leaving no chances. Interestingly, the Bt gene used in brinjal is the same used in Bt cotton. The GEAC has been fast in approving Bt cotton for cultivation. In 2002, only 3 Bt cotton hybrids were under cultivation in a limited area in south India. Today there are 59 Bt cotton hybrids of different seed companies under cultivation in different cotton growing regions of the country. The GEAC in 2005, however, had discontinued cultivation of Mahyco's three Bt cotton hybrids in some areas on receiving adverse reports of its performance. However, the case of Bt brinjal, being a food crop is of sensitive nature. It is already in the midst of controversy with Mahyco (Indian joint venture of American seed giant, Monsanto) claiming its health and environment safety and NGOs and farmers’ organisations, alongwith a group of scientists, disputing its claims, citing some evidences. The controversy gains importance in the light of the fact that brinjal is used in India not only as food but also as a medicine in the traditional system. Mahyco claims that its four Bt brinjal hybrids – MHB-4 Bt, MHB-9 Bt, MHB-80 Bt and MHBJ-99 Bt — are resistant to fruit and stem borer — one of the major pests on the crop. It is safe for animal and human consumption. Dangers of cross pollination is negligible as pollen flow is up to a maximum of 20 metre distance. The GEAC has put up company’s claims on the website and invited public comments. Studies done at Mahyco Research Centre show that transgenes (Cry 1 Ac, Npt1 gene, aad gene) in Bt brinjal behave as a single gene, dominant Mendelia factor and are stably integrated in the plant genome. The protein causes death to the insect by disrupting its digestive process and not to non-target species. Mahyco also claims that Cry1Ac, the Bt toxin used in Bt brinjal, is non-toxic in nature. Mahyco in its presentation before the GEAC said that the brinjal plant is usually self-pollinated. However, the extent of cross-pollination is believed to be as high as 48% and hence, it is often classified as a cross-pollinated crop. It listed 22 Indian species of genus Solanum (brinjal) The NGOs and farmers groups, in this context, said that pollen flow can occur up to kilometers and endanger traditional varieties and wild relatives. It would jeopardise the situation as India is one of the centre of origin brinjal biodiversity. NGOs and farmers' organisations have said Bt gene is a known toxin that impacts human and livestock health adversely: They cited reports of mortality of 10,000 sheeps grazing over Bt cotton fields in Andhra Pradesh, which is under probe. Responding to this, the GEAC has decided to take up leafy toxicity studies. Noted nutrition expert and toxicologist, Arpad Pusztai has come to their rescue and said: "Studies have revealed that toxin form of Cry1Ac is potent antigen in mice, following gastric administration. Specific IgG and IgM antibodies and locally produced IgA and IgG antibodies to the toxin were detected. Several human cell cultures, including colonic epithelial and liver cells, demonstrated a number of cytotoxic reactions when exposed to Bt toxins and immunologic sensitisation of farm workers has been well documented. Accordingly, it would be unwise to use Bt toxin-containing foodstuffs for human or animal diet." Norwegian scientist Marjt R Myhre and his team found the plant virus promoter (35S CaMV) used in Bt brinjal "active in human enterocyte-like cells." The NGOs in their representation to GEAC also cited several studies done by scientists at the Center for Genetic Engineering. They have begun lobbying with agriculture minister Sharad Pawar, health minister Ambumani Ramadoss and environment minister A Raja trying to convince them with their arguments. Aruna Rodrigues and others have filed a suit in the apex court asking for a moratorium on approval of GM crops. The hearing of the case is in process. On the apprehensions of environmentalists, sources in department of biotechnology say, "We want to go to the market with transgenics but will never compromise with bio-safety." While issues of efficacy of transgenic gene against pests and bio-safety will be addressed during large-scale field trials, for the consumers the proposed legislation on food labeling is expected to provide a safeguard. 4.To the Governor of Madhya Pradesh To Respected Sir Sub: Bt BRINJAL – BIOSAFETY AND BEYOND We are a group of concerned civil society organizations consisting of leading farmers’ unions, consumer organizations, organic farming groups, NGOs working on environmental and sustainable agriculture issues, women’s groups, members of the medical fraternity etc., representing in turn lakhs of Indians, approaching you to intervene into the matter of Bt Brinjal, which is on the verge of obtaining permission for large scale trials and seed production in this country. This is a worth mentioning fact that very recently Government of Uttranchal in a very remarkable sept has banned all kind of GM production in their state. We expect that Governemnt of Madhya Pradesh will also look forward for banning GM agriculture in the state because it has been experienced that BT Technology is not at all supporting our farmers. This would be the first time that a GM food crop could be allowed to be released into the open environment for this stage of research. This is also the first time in the world that a GM vegetable crop would be grown with the Bt toxin incorporated into it and consumed with very little or even no processing or cooking. It is not out of place to remind here that it was during large-scale trials that Bt Cotton’s illegal proliferation began in this country and the regulators only watched with helplessness. Things have not improved an iota since 2001 when such contamination began with Bt Cotton in this country. There are grave concerns with regard to these various developments and since the Environment Ministy’s mandate is to protect the Indian environment and the environmental health of all Indians and since the Ministry constitutes one of the important regulators of GM in agriculture in India [by virtue of the GEAC located in the Ministry and by the presence of the Ministry’s representatives in the GEAC] we approach you to seek your urgent positive intervention in the issue. We would like to begin by stating that while we welcome the fact that GEAC has offered, for the first time more than a decade after GM crop research began in India; to put up data related to findings from biosafety tests on Bt Brinjal, the entire process run was completely unacceptable. The data that was put up, as presentations by M/S Mahyco to the GEAC, is completely inadequate for any intelligent and scientific feedback to be provided. This also showed the world how GEAC takes its decisions. It is clear that a body that should ask basic, scientific questions related to health and environmental implications in addition to socio-economic implications for our farmers, has decided to function as a mere 'bureaucratic approval' body and runs its processes only on such company-produced meaningless presentations. This is a shame to this country, which is a signatory to international conventions like the Cartagena Biosafety Protocol that enshrine the concept of biosafety when it comes to GMOs. To make this farcical process worse, GEAC’s own press release put out through the PIB [Press Information Bureau] on May 25th, 2006 says that the company's biosafety findings would be put up under the sub-heading "GEAC Clearance Shortly" on the MoEF's website. Does that mean that the GEAC has already decided on the clearance shortly? We provide our feedback on Bt Brinjal hereunder. Below, we bring up biosafety issues as well as more fundamental issues beyond biosafety. Much of this feedback should also serve as a feedback on the serious shortcomings of our biosafety regime in general and why there is a need to invoke the precautionary principle on GM crops. 1. There is no justifiable reason whatsoever for experimenting on and introducing Bt Brinjal [and GM crops in general]: The GEAC or the DBT [Department of Biotechnology] has no good reason and justification to promote a GM Brinjal in this country. Pest management on Brinjal is being successfully practiced by numerous IPM, NPM and organic farmers with non-chemical, non-GE approaches with very satisfactory results all over the country. Within the ICAR establishment, numerous research projects, including on farmers’ fields, show that there are very good, inexpensive and absolutely safe results following non-chemical IPM methods in particular and IPM methods in general. Given such vast experience, why is there no political will to put the control over the technology in farmers’ hands? which should provide a way forward for our thinking. We are once again reiterating that for the pest management paradigm to shift in this country, what is needed is political will and not GE-like solutions. We all know that pesticide use in fact has very little to do with pest/disease incidence any more and it has suited the pesticide industry and the regulators/agriculture scientists very well to encourage such a situation so far. To get out of this, we don’t need a technology-fix but an alternative paradigm of pest management which empowers the farmers to understand their farm ecology and depend on local resources and sustainable practices for pest management. More importantly, there is no crisis with Brinjal production. In fact, due to overproduction, farmers do not get adequate market price. 2. The science is imprecise and the technology unpredictable – Impact Assessment to be broad in scope: It is well known that GE is based on imprecise science and is an unpredictable technology as there is little control on where the new genetic construct will lodge within one or more of the target cell chromosomes. It is also well known that tests are not conducted to assess the results from the variety of genes that are inserted along with the desired gene [the markers, promoters, terminators etc. etc.]. Scientists do not understand the mechanisms of GE-induced changes in gene expression in sufficient detail. They do not know what to look for and these things are termed ‘unintended effects’. It is for this reason that on a whole range of issues, a great deal of research is required before any outcomes can be predicted in a reasonably assured manner. Unlike in other countries, in a country like India where a majority of our livelihoods depend on agriculture, any irrevocable or irreversible change to our agriculture needs to be reasonably sure that the benefits being projected are drawn from sound, long term scientific testing and that risk assessment parameters are broad-based. Elsewhere, risk assessment of GMOs also asks a very pertinent question – "is it [introduction of a GMO] socially and ethically justifiable?". We are so that GEAC might at least now pick up the appropriate framework for risk assessment given that millions of farmers in this country would be affected by your decisions. 3. India is a Center of Origin and diversity for Brinjal: Our pool of genetic reserves would inevitably be contaminated and this is extremely dangerous given that we are a Centre of Origin and diversity for Brinjal. We have grown Brinjal for the past 4000 years in this country and it is an extremely popular and widely consumed vegetable. Needless to say, horizontal gene transfer from Bt Brinjal into wild, related species of brinjal has serious implications for the very future of Brinjal research and cultivation in the country. The genetic diversity is important because some of the strains will be naturally resistant to lethal pathogens and pests that may destroy the crops in the future. Once lost, this lack of diversity can lead to the complete loss of the crop. If the gene confers an advantage to the wild plants, it will spread in those plants and cause possible harm. This is a very different risk then for the crop itself, since most crops, unlike their wild relatives, cannot survive without cultivation. The U.S. National Academies of Science, in a report in 2004, said that genes that control pests, like Bt genes, have a good chance of giving wild plants an advantage and thereby spreading in the environment. Several published experiments with Bt in rapeseed and sunflower have provided preliminary data that Bt genes can indeed give some wild plants a competitive advantage. If the gene spreads in wild relatives of brinjal, its escape into the environment will likely be permanent. The toxin produced by the gene may then kill insects that feed on the wild plants. These insects, in turn provide food for other organisms such as birds and mammals, which may then suffer harm. For these reasons, it is important to determine the possible harmful effects of the Cry1Ac gene in sexually compatible wild relatives and their ecosystems. The Cartagena Protocol on Biosafety, the only international law to specifically regulate genetic engineering and GMOs (largely focused on transboundary movement, but whose scope also applies to the use of all GMOs), recognises the importance of centres of origin and diversity, and requires this to be taken into account during the risk assessment. How has this principle been applied in the case of Bt Brinjal in India? 4. Potential environmental hazards with Bt Brinjal: Existing evidence on environmental hazards with GM crops is enough for a precautionary principle to be invoked regarding their regulation. For instance, it was found in studies that GM crops grown in the UK were not only harmful to beneficial insects like ladybirds but could also indirectly harm other and higher life forms, including mammals, domesticated or wild animals/birds and ultimately man, both in the short- and long-term. The three-year UK farm-scale trials were the largest study ever to evaluate some of the ecological effects of GM crops. v The assessments about frequency and importance of Horizontal Gene Transfer are premature at present. It is accepted that it [HGT] could have an environmental impact even at a frequency that was approximately trillion times lower than what the current risk assessment literature assumes it to be. The current methods of environmental sampling to capture genes or traits in a recombinant manner are too insensitive for monitoring evolution by HGT. This has serious implications for our bio-diversity, especially given that we are the Centre of Origin for brinjal. With the inevitable contamination of the seed stock, which is certain to take place with GM crops, recovering the original genetic stock will be impossible. v In the case of pollen flow, it is well known that there is ample opportunity for cross pollination in the case of Brinjal. The rates of natural cross pollination may vary depending on genotype, location, insect activity etc. However, it has been reported that the extent of natural outcrossing is from 2 to 48% in the case of India. Further, it is not clear whether there is enough data on the wild and weedy plants that are either close relatives or have some degree of cross-compatibility with these brinjal varieties. No tests have been done to check for cross-pollination with such relatives. The pollen flow studies on Bt Brinjal in India have been done only in one year [2002, even as the backcrossing programme was on?], in two locations, with reported outcrossing put at 1.46% and 2.7% in these two locations. Such pollen flow studies cannot obviously rely on data from one season and two locations. Studies elsewhere have shown that the likelihood of outcrossing from genetically engineered crops is much higher than in non-engineered crops. For obvious reasons, the same care that is taken for maintaining seed production standards [of 200 metres], has to be applied for the worst case scenario with Bt Brinjal, as a very minimum requirement. In such a case, will Bt Brinjal farmers, who are mostly small and marginal farmers, be able to conform to such guidelines? v Further, farmers from various parts of the country are reporting a decline in their soil productivity after growing Bt Cotton. While the regulatory tests related to Bt toxin presence and persistence in the case of Bt Cotton showed that the half-life of Cry1Ac protein in plant tissue was calculated at 41 days [which could then persist in the soil as other studies from elsewhere show], it is not clear how in the case of Bt Brinjal it is non-detectable in soil samples tested. Worldwide, it is generally accepted that Bt toxin does alter the soil micro-biology and that more studies are needed to understand the impact of Bt toxin on soil ecology. v Have the regulators studied the impact of Bt Brinjal on ecologically sensitive areas like the Eastern and Western Ghats and considered how they would prevent the entry of Bt Brinjal into such ecologically sensitive areas? v We should also consider a scenario where our predominant pest management strategy relies more and more on one gene – the Bt toxin gene, across crops for a range of pests. Such a monoculture of the gene across crops and varieties is bound to spell doom sooner or later. v Resistance is already predicted in the target pest and resistance management strategy suggested is a 5% refuge. However, Bt Cotton experience shows that farmers do not follow these resistance management strategies. How will this be done in the case of Bt Brinjal, especially with the farmers being mostly small and marginal? If there are several GM crops grown together, the resistance build up will be faster. 5. The Bt gene is a known toxin that impacts human health and livestock health adversely: Numerous studies worldwide have raised serious questions about potential health impacts of delta-endotoxins. Key assumptions used as the basis for safety claims have been overturned and several adverse findings suggest that GM foods are unsafe. GM-fed animals had problems with their growth, organ development and immune responsiveness, blood and liver cell formation as well as damaged organs [bleeding stomachs, excessive cell growth, inflammation in lung tissue], sterility problems and increased death rates including among the offspring. Risks are increased by the fact that the genes inserted into GM food not only survive digestion, but transfer into body organs and circulation. Transgenes or their fragments have been found in the blood, liver, spleen and kidneys. Introduction or creation of a new or known allergen or toxin is a potential consequence of genetic manipulation, as experience worldwide shows. When Bt Cotton was introduced in India, the same set of tests that are now being applied for Bt Brinjal have apparently been run by the company involved and everything was proclaimed to be safe. However, the human health effects of Bt Cotton in India are being reported from all cotton-growing states. Most farmers and farm workers are experiencing allergies of different kinds. Further, a recent scientific investigation made a clear correlation between the exposure to Bt Cotton and these adverse health effects. There were also reports on mortality of sheep after grazing on Bt Cotton recently. While there have been no systematic investigations done in other places, there are informal reports however that livestock is being adversely impacted upon grazing on Bt Cotton fields from other places too. While this is the case with cotton, the consequences with a food crop, that too a vegetable crop which will be consumed quite directly, are unimaginable. Never before in the world has the Bt toxin been introduced into a vegetable crop, where the toxin would be consumed in large quantities and without much processing, the Bt gene being used in Bt Brinjal, has many established adverse health impacts. These published, peer reviewed papers by scientists demonstrate that recombinant Cry1Ac protoxin is a powerful immunogen (able to produce an immune response), and when fed to mice, induced antibody responses similar to those obtained with the cholera toxin. Research shows that Cry1Ac actively binds to the inner surface of the mouse small intestine. This contests the often-heard argument that Cry proteins don’t affect mammals since they supposedly do not have receptors that bind the truncated toxin in the gut! The entire infamous episode of Starlink contamination [where Cry9C toxin was used] raises the question of whether other Bt toxins that were supposedly screened might nevertheless be allergens. Scientists accept that without a better understanding of food allergenicity, this question cannot be adequately answered. There are serious limitations to current allergy testing procedures for GMO proteins. For example, recent results in Australia revealed that a protein previously consumed safely in beans had become immunogenic (similar to allergic reaction) when engineered into GMO peas. The immunogenicity of the GMO peas would not have been detected by currently used tests. Therefore, new allergy tests, and careful, long-term tests, are needed to assure the safety of Bt brinjal. Other possible risk issues, such as possible unintended harmful changes in the Bt brinjal plants, can also only be addressed by careful long-term and other testing. We cannot afford to make the mistake committed by Australian regulators who discovered the GM peas case only after almost irreversible field trials. There are some nutritional and toxicological studies carried out on ingested plant GM DNA which provide information on the potential nature of the hazards of GM foods/feeds. These include: wasteful growth of gut tissues and bacterial proliferation, development of intestinal tumours, depression of the body’s immune system, interference with the normal development of vital organs of the body (liver, kidneys, sexual organs, etc.) and reproduction. The seriousness of these effects cannot be overemphasized because the harm will be the most pronounced in the young, the old and in people with intestinal disorders. A human clinical study carried out and published provides strong evidence of Horizontal Gene Transfer from food to humans. This study showed that fragments of GM DNA were incorporated into the bacteria resident in the gut of human volunteers. Significant amounts of transgenic DNA is found to survive most commercial processing or in the gut of mammals, as per studies in various places. 6. The other genes introduced are toxic too: Antibiotic resistance: In creating Bt Brinjal, NptII gene has been used as a selectable marker. NptII codes for kanamycin resistance and globally, there are serious concerns with antibiotic resistance marker genes for obvious reasons – when there is horizontal gene transfer to gut or soil bacteria, this could spread antibiotic resistance widely. Gene flow, especially to pathogenic organisms, related to antibiotic resistance has been established in past studies. This will imply that disease treatment would be more and more difficult. The Bt Brinjal also has an aad marker gene. Streptomycin resistant marker according to EFSA is a potentially dangerous marker to animals and human beings and should not be used in the case of GM plants used as food. Transcriptional activity in human cells with CaMV 35 S: Similarly, use of the CaMV 35 S [cauliflower mosaic virus] promoter, used in creating Bt Brinjal is a matter of concern. Published research shows that the 35S promoter can initiate transcriptional activity in human cells, despite the promoter being a plant-specific one. The cauliflower mosaic virus (CaMV), the viral promoter used in Bt Brinjal has similarities with the human hepatitis B virus. As all genomes of living species contain dormant viruses, there is a potential for the CaMV promoter to reactivate them raising concerns related to cancers. One of the major omissions in present day GM risk analysis is that no attempt has so far been made to investigate the obvious link between GM food and intestinal tumour development. As Dr Arpad Puzstai points out, "full reproductive experiments are required in which the reproductive performance of both male and female rats fed on GM- versus non-GM diets should be monitored for several generations because any problems with reproduction could have disastrous consequences for the environment". The problems encountered in the study of ‘growth factor-like’ effects on young rats, was attributed most likely, to the CaMv (cauliflower mosaic virus) viral promoter, a promoter put into Bt Brinjal too. Evidence suggests that the CaMv 35S promoter might be especially unstable and prone to horizontal gene transfer and recombination with all the attendant hazards: gene mutation, cancer, re-activation of dormant viruses and generation of new viruses. Hazards from GM crops released into the environment may spread more readily through Horizontal Gene Transfer because GM constructs are specifically designed to cross the interspecies barrier. 7. Past history with corporate research shows suppression of important information: Monsanto, which is supplying the technology to Mahyco and others in the case of Bt Brinjal, is known from past experience to suppress facts that are unfavourable to the company and its potential markets. A secret study on Bt Maize showed significant harm caused to rats fed on the variety called MON 863. The study shows kidney abnormalities and unusually high levels of white blood cells. What is shocking was that the company then went ahead to conclude that these findings were irrelevant and should not be attributed to Bt Maize even though the rats fed on non-Bt Maize showed no such signs! Given such dubious history, how are the regulators relying on data produced only by the company? There is a serious and objectionable conflict of interest in the fact that majority of the tests were undertaken by the company promoting Bt Brinjal [pollen flow studies, Cry1Ac protein expression, baseline susceptibility, protein estimation in cooked fruits, soil analysis, substantial equivalence studies etc. etc.]. Out of the various tests conducted, only four were conducted by public sector institutions. All the tests were funded by the company Where are independent studies to verify the claims of the company? 8. The tests done here are not adequate – Are we even asking the right questions? A Public Interest Litigation [PIL] on the lack of rigorous biosafety testing for GMOs in India points out that the current biosafety regime is woefully inadequate in India for ready reference. Often, we do not even have the right questions to ask when testing for safety of GMOs. As pointed out earlier, elsewhere, biosafety regime is inclusive of such pertinent questions as "is this socially and ethically justifiable?". This requires the testing to be done against other known safer alternatives including ecological/sustainable agriculture practices. However, this was not done in the case of Bt Brinjal. By Dr Pushpa Bhargava way back in 2002 outlines what the biosafety regime should constitute. Going by the set of studies that the company has been asked to do by the regulators, it is obvious that feedback has not been picked up and lessons not learnt. 9. The agronomic data unreliable and manipulated: Going through the Annual Report of the All India Coordinated Research Project – Vegetable Cultivation on ICAR-supervised Bt Brinjal multi-locational trials in 2005-06, it is clear that the data presented is manipulated and unreliable. It is not clear why at least 3 out of the 11 Centres for trials did not report back. The data was not statistically analysed and wrong conclusions were drawn based on skewed averages. It is not clear how some centres could obtain such unbelievably high yields while most of the centres were below average. Is this going to be the situation in real life too for farmers? There is no data at all on pesticide use obtained through the trials though Bt Brinjal is developed ostensibly to reduce the use of pesticides. It is also clear that there were no trials taken up to compare with safer, cheaper, farmer-controlled alternatives like organic brinjal cultivation or NPM or IPM approaches. There was not even a comparison against IPM experience from all over the ICAR establishment from more than 10 years’ of work. 10. Pending liability issues with regard to biosafety violations that need to be addressed first: Right from the first GM crop trials, there have been many reports from the civil society and the media which pointed out to serious GM regulatory failures in India. This failure was evident both from the company’s side [one doing GM research] and from the side of the regulators like the DBT and the GEAC. Such failure of enforcement inevitably led to contamination of the supply chain from most field trials even before biosafety [within its limited framework in India] tests were completed. In the case of Bt Brinjal too, investigations of a field trial in Kurnool district of Andhra Pradesh pointed out to the fact that the farmer was allowed to sell the Bt Brinjal in the local market. Even though this was brought to the notice of the regulators, no action towards fixing liability for such serious violations was initiated. One of the issues that emerged from investigating the Bt Brinjal trial in Kurnool was the observation by the farmer and his relatives that Bt Brinjal needed to be sold only in the mornings when its color was attractive and that it would change color as the day passed! Farmers’ observations about such issues are very sharp and this needs serious and deeper investigation. This was later corroborated by the field assistant employed by Mahyco, in a telephonic conversation. 11. Economic implications: There are serious economic implications for farmers if India opts for Bt Brinjal. The assessment of such implications would be clear compared against other choices like staying non-GM as well as promoting organic farming. Even a country like Germany had experienced the enormous employment opportunities provided by the organic approach. In a country which should adopt labour-intensive technologies, organic and other sustainable farming options are a viable proposition. On the other hand, transgenic agriculture would sound a death knell for any attempts related to organic farming in India. Contamination is inevitable and co-existence impossible. This would have serious economic implications for the farmers here. Further, it would clearly negate the efforts being put in by the Government of India to promote organic farming in recent times. This is a clear policy-level contradiction. 12. Consumer choices and rights: Transgenic contamination (contamination of the natural environment by GMOs) by more than one method, including wind blown and by cross- pollination is an established fact, beyond dispute and there can be no co-existence between GM and non-GM crops. Segregation even at the physical level is impossible in India. What happens to consumer choices and rights in such a case? Where would be the consumer’s right to choose in the case of vegetables, even if we assume that segregation upto an extent is possible and labelling could be made mandatory? Indian vegetable purchases from supermarket shelves are minuscule and obviously, labelling is not going to be an answer here. How do we then provide non-GM brinjal to Indian consumers? 13. Proprietary Rights of the company: Even as the ABSPII project was publicising through the media that the technology would be available to the Indian public sector and later to the farmers on a cost-to-cost basis, with Monsanto providing the technology and Cornell University/USAID facilitating the process, Mahyco has informed the GEAC in its presentation on May 22nd that it had applied to the Patent Authority for a patent for "this unique event". This of course will open the floodgates of Indian seed industry to patents, which needless to overemphasise will violate farmers' rights. It will also mean that this technology will not be for everyone, though it is being projected otherwise! The true colors of the corporations behind the development of Bt Brinjal have begun showing. In conclusion, drawing from the experience with another hazardous technology like pesticides, it is obvious that biosafety and impact assessments are not carried out before irreversible release of the technology into the environment. Very often, experimentation is done at the expense of poor Indians including Indian children as scapegoats. Can India afford to make similar mistakes again? Given all the above, we demand that: 1 Since the effects of this technology/modified organism are unknown and since these are potentially hazardous, the use of this technology and release of those organisms must wait until the hazards are properly understood and the effects known. This requires the precautionary approach to be followed. 2 Biosafety testing should include testing for medium and long term effects on the environment and human/animal health, in addition to asking questions on the justification of releasing the GMO into the open environment on social and ethical grounds. For this, the regulators as a beginning, should put together all the available data on safer alternatives, as any environment assessment should, like IPM, NPM, organic etc., and compare Bt Brinjal with such alternatives. 3 Proper biosafety tests should be taken up by independent and scientifically competent bodies in a transparent manner. Such tests should be allowed to take appropriate time needed to understand the medium and long term effects instead of being hastened in the pursuit of ‘fast-track approvals’. 4 The results of such tests should be made public and data published in a manner that it can be closely examined by the scientific community. It shall also be presented to all primary stakeholders [farmers and consumers] in a manner that meaningful debates are possible, through for instance, mandatory public notice and public hearings etc. 5 Such reviews and debates should also look at issues beyond biosafety and delve into socio-cultural and political aspects related to GM agriculture, given that millions of our lives and livelihoods depend on agriculture here in India. 6 The GEAC, especially representatives from the Environment Ministry should take on board current scientific data [health and environmental] from elsewhere to understand the potential impact of GMOs and to ask the relevant questions in the Indian context. Based on such available data, they should lucidly justify why a precautionary principle cannot be invoked straightaway, instead of falling into the trap of the Department of Biotechnology which apparently has only one mandate of promoting GMOs. In summary, we demand that the Environment Ministry as one of the most important stakeholder-regulators of GMOs in this country play its rightful and expected role in protecting the Indian environment, the health interests of Indians. For this, we demand that the Ministry take a precautionary approach and reject the proposal to permit Bt Brinjal large scale trials in the country. Nilesh DesaiBeej Swaraj AbhiyanMob. 094253 29222 Mr. A.K. Gupta |
|